| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Chief Technical Officer
1 company
Jose Manuel Otero is Chief Operating Officer at LXEO. Jose Manuel Otero's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $430K at current prices.
Historically, Jose Manuel Otero's trades have earned a middling insider score of 57/100 across 5 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +36.1%.
The LXEO filings lean toward selling, a net 15,972 shares.
Jose Manuel Otero has 13 Form 4 filings on record from June 2024 to September 2026, all as Chief Operating Officer at Lexeo Therapeutics (LXEO), 2024–2026.
The 20 reported transactions were 8 stock awards, 8 open-market sales and 4 option or other derivative awards.
Counted by filing, the open-market trades come to no purchases and 7 sales worth about $92K.
The largest open-market sale was 4,666 shares of LXEO at an average $4.48 on July 1, 2026, about $21K.
None of the 7 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Chief Operating Officer | Sell | 1,304 | $4.96 | $6,464.06 | -0.9% | - | - | |
| Jul 1, 2026 | LXEO Lexeo Therapeutics, Inc. | Chief Operating Officer | Sell | 4,666 | $4.48 | $20,903.68 | -3.3% | -23.1% | - | |
| May 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Chief Operating Officer | Sell | 1,302 | $5.07 | $6,606.35 | -1.0% | +5.7% | - | |
| Feb 18, 2026 | LXEO Lexeo Therapeutics, Inc. | Chief Operating Officer | Sell | 3,016 | $6.40 | $19,293.96 | -2.3% | -28.8% | - | |
| Oct 17, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Technical Officer | Sell | 2,115 | $8.94 | $18,912.55 | -3.2% | -21.7% | -72.4% | |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Technical Officer | Sell | 721 | $9.27 | $6,683.67 | -1.1% | +92.7% | +0.2% | |
| Aug 18, 2025 | LXEO Lexeo Therapeutics, Inc. | Chief Technical Officer | Sell | 2,848 | $4.67 | $13,294.46 | -4.5% | +92.7% | +0.2% |